Millennium Management’s Armata Pharmaceuticals ARMP Stock Holding History

Millennium Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.64M	Buy	257,992 +231,904	+889%	+$1.95M	﹤0.01%	3602
2025 Q4	$164K	Buy	+26,088	New	+$143K	﹤0.01%	5524
2023 Q2	–	Sell	-11,130	Closed	-$19K	–	6085
2023 Q1	$19K	Sell	11,130 -4,455	-29%	-$10.3K	﹤0.01%	5875
2022 Q4	$19K	Buy	+15,585	New	+$40.6K	﹤0.01%	6059
2021 Q3	–	Sell	-10,055	Closed	-$40K	–	6754
2021 Q2	$40K	Sell	10,055 -5,346	-35%	-$22.5K	﹤0.01%	6391
2021 Q1	$74K	Buy	+15,401	New	+$75.7K	﹤0.01%	5732
2015 Q4	–	Sell	-73	Closed	-$40K	–	3397
2015 Q3	$40K	Buy	+73	New	+$66.7K	﹤0.01%	3361

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's ARMP Position: Q1 2026 in Review

Millennium Management increased its Armata Pharmaceuticals (ARMP) stake by 889% in Q1 2026, buying an estimated $1.95M and bringing the position to 257,992 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

Millennium Management first reported a position in ARMP in Q3 2015 and has held it in 7 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

Millennium Management held 257,992 shares of Armata Pharmaceuticals worth $2.64M as of Q1 2026.
Millennium Management bought 231,904 Armata Pharmaceuticals shares in Q1 2026, an estimated $1.95M.
Armata Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3602 holding.
Millennium Management first reported a position in Armata Pharmaceuticals in Q3 2015 and has held it in 7 quarters since.
45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.